✦ LIBER ✦

Soluble II-2 receptor serum levels — a marker for disease progression in patients with HIV-1 infection

✍ Scribed by C. Schulte; M. Meurer

Publisher: Springer-Verlag
Year: 1989
Tongue: English
Weight: 475 KB
Volume: 281
Category: Article
ISSN: 0340-3696
DOI: 10.1007/bf00412971

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elevated serum levels of soluble interle

Elevated serum levels of soluble interleukin 2 receptors in HIV infection: correlation studies with markers of cell activation

✍ J.M. Lang; G. Coumaros; S. Levy; A. Falkenrodt; M. Steckmeyer; M. Partisani; A. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Standardized uptake value on FDG-PET as

Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin’s lymphoma: comparison with serum soluble interleukin-2 receptor values

✍ Mitsuaki Tatsumi; Hiroyuki Sugahara; Ichiro Higuchi; Hiroki Fukunaga; Hironobu N 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 657 KB

Association between serum levels of solu

Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy : A Gynecologic Oncology Group study

✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics

Thalidomide in combination with dexameth

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival

✍ Philipp Schütt; Peter Ebeling; Ulrike Buttkereit; Dieter Brandhorst; Bertram Opa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 132 KB

Circulating advanced glycation end produ

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes

✍ Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Takanori Matsui; Yayoi Kurit 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views